Institutes

Clinical

Education
  Continuing Medical Education
  Graduate Medical Education
  Medical Student Education
  Nursing Education

Hollis Health Sciences Library

Research
  Bone Mineral Research
  CardioPulmonary Res. Inst.
  Clinical Trials Center
  Institutional Review Board
  Office of Sponsored Programs
  Vascular Biology Institute


Article Tools
 Print this page
 Email this page

Vascular Biology Institute (VBI)
  • Research Interests
  • Faculty / Staff
  • Recent Publications
  • Funding Agencies
  • Contact Information

    Research Interests:

    Dr. Louis Ragolia, Ph.D.; - Principal Investigator
    Dr. Louis Ragolia, Ph.D.;
    Principal Investigator
    Vascular Biology Institute research focuses on the pathogenic mechanisms responsible for the development of cardiovascular complications observed in diseases such as Diabetes, Hypertension, and Kidney Failure. Using a wide range of biochemical methodologies including molecular biology, array technology, tissue culture, histopathology, and transgenic animals, they are examining the regulation of signal transduction proteins in response to cell cytokines and studying their effects on vascular remodeling. In addition, they are identifying any defects in the diseased states, with the anticipation of finding potential target sites for drug development and gene therapy. The program is based on the integration of basic scientists with clinicians in the fields of endocrinology, gastroenterology, nephrology, pulmonary, and rheumatology.

    Faculty / Staff:

  • Louis Ragolia, Ph.D., Director
  • Allison B. Reiss, M.D., Research Scientist
  • Jinhee Lee, Ph.D., Postdoctoral Research Scientist
  • Thomas Palaia, M.S., Senior Research Technician
  • Christopher E. Hall, B.S., Research Technician II
  • Lisa Urgolites, M.S., Research Technician II
  • Hongwei Zhang, M.D., Research Technician II

    Recent Publications:
    Mouse Aorta cross-section
    Mouse Aorta cross-section

    • Ragolia, L., Palaia T., Koutrouby, T.B., and Maesaka J.K. 2004. “Inhibition of Serum-induced Cell Cycle Progression and Migration of Vascular Smooth Muscle Cells by Prostaglandin D2 Synthase: Resistance in the Diabetic Goto-Kakizaki Rat Model” Am. J. Physiol Cell Physiol. 287: C1273 – 1281.
    • Ragolia, L., Palaia T., Paric E., and Maesaka J.K. 2003. "Prostaglandin D2 Synthase Inhibits the Exaggerated Growth Phenotype of Spontaneously Hypertensive Rat Vascular Smooth Muscle Cells" J. Biol. Chem., 278:(24), 22175-22181.
    • Ragolia, L. Palaia, T., Paric, E., and Maesaka, J.K. 2003. "Elevated Prostaglandin D2 Synthase Activity Contributes to PMA-induced Apoptosis in LLC-PK1 Cells Concomitant with Down-regulation of PI3-K" Am. J. Physiol. Cell Physiol 284: c119-c126.
    • Maesaka, J.K., Palaia, T., Fishbane S., and, Ragolia, L. 2002 "Contribution of Prostaglandin D2 Synthase to Progression of Renal Failure and Dialysis Dementia" Sem. Nephrol. 22(5):407-414.
      Electron Microscope (Thomas Palaia, M.S.)
      Electron Microscope (Thomas Palaia, M.S.)
    • Maesaka, J., Palaia, T., Frese L., Fishbane, S. and Ragolia, L. 2001. "Prostaglandin D2 Synthase Induces Apoptosis in Pig Kidney LLC-PK1 Cells" Kidney Int'l. 60(5):1692-1698.
    • Ragolia, L., Palaia, T., Frese L., Fishbane, S. and Maesaka, J.K. 2001. "Prostaglandin D2 Synthase Induces Apoptosis in PC12 Neuronal Cells" NeuroReport 12:1-6.
    • Begum, N., Sandu, O., and Ragolia, L. 2000. "Diabetes is Accompanied by Impaired Insulin-Mediated Myosin-Bound Phosphatase Activation and Vascular Smooth Muscle Cell Relaxation due to Defective Rho Kinase and Nos Signaling" Diabetes 49(12):2178-2189.
    • Begum, N., Duddy, N., Sandu, O., Rienzie, J. and Ragolia, L. 2000. "Regulation of Myosin-bound Protein Phosphatase by Insulin in Vascular Smooth Muscle Cells: Evaluation of the role of Rho Kinase and PI3-Kinase dependent signaling pathways" Mol. Endocrinol. 14: 1365-1376.
      Florescence Imaging (Tara Koutrouby, M.S.)
      Florescence Imaging
    • Ragolia, L., Zuo, Q., and Begum, N. 2000. "Inhibition of Myogenesis by Depletion of the Glycogen-associated Regulatory Subunit of Protein Phosphatase-1 in Rat Skeletal Muscle Cells" J. Biol. Chem. 275:26102-26108.
    • Begum, N. and Ragolia, L. 2000. "High Glucose and Insulin Inhibit Vascular Smooth Muscle Cell MKP-1 Expression by Blocking iNOS via p38 MAPK Activation" Am. J. Physiol. Cell Physiol. 278: C81- C91.
    Funding Agencies:

  • American Diabetes Association
  • American Heart Association
  • Amgen Pharmaceuticals
  • National Institutes of Health
  • Winthrop-University Hospital Department of Medicine

    Job Opportunities

    Please visit the Employment section of winthrop.org for more information.

    Contact Information:

    Louis Ragolia, Ph.D.
    Director, Vascular Biology Institute
    Associate Professor, Stony Brook University
    Winthrop-University Hospital
    222 Station Plaza North, Suite 505-B
    Mineola, NY 11501
    Phone: (516) 663-2028
    E-mail: LRagolia@winthrop.org



  • [ Home | Search | Contact | Directions | Privacy Notice ]

    Winthrop-University Hospital | 259 First Street | Mineola NY 11501 | 516-663-0333

    This site provides information as a resource. It is not a substitute for professional medical advice.
    Always consult a physician or healthcare provider for treatment and guidance toward good health.
    Copyright © 2008 Winthrop-University Hospital. All rights reserved. Long Island Web Design